FWM
CLVS

Focused Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Focused Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,300
Closed -$12K – 741
2015
Q3 		$12K Buy
+1,300
New +$113K 0.01% 376

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Focused Wealth Management's CLVS Position: Q3 2018 in Review

Focused Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 1,000 shares — an estimated $45K sold.

Focused Wealth Management first reported a position in CLVS in Q2 2015 and held it in 13 quarters. The position peaked at $175K in Q3 2016. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • Focused Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • Focused Wealth Management sold 1,000 Clovis Oncology, Inc. shares in Q3 2018, an estimated $45K.
  • Focused Wealth Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 13 quarters.
  • Focused Wealth Management's Clovis Oncology, Inc. position peaked at $175K in Q3 2016.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Focused Wealth Management's 13F filing for Q3 2018, filed 13 Nov 2018.